Dilated cardiomyopathy is part of the spectrum of heart failure which is a syndrome with certain morphological and functional characteristics. Although significant progress in the management of those patients has been achieved, seems that risk stratification and future treatments will be related to the specific pathological substrate.
Keywords: Arrhythmogenic cardiomyopathy (ACM); Dilated cardiomyopathy (DCM); Genetics; Hypo kinetic non dilated cardiomyopathy(HNDC); Risk stratification.
Copyright © 2018 Elsevier B.V. All rights reserved.